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Background
One of the hallmarks of HIV infection is an early and
dramatic depletion of CD4 T cells in the intestinal lamina
propria. This loss of T cells is accompanied by intestinal
epithelial cell disruption resulting in the translocation of
luminal bacterial products, persistent systemic immune
activation and resultant disease progression. Beta defen-
sins are cationic antimicrobial polypeptides produced by
intestinal epithelial cells and phagocytes that are a part of
the innate immune response. They have a pivotal role in
maintenance of immune homeostasis in the gut.
Although beta defensins have been reported to inhibit
bacterial and viral replication in vitro, their role in HIV
infection has been incompletely characterized.
Methods
We investigated anti-viral activity and production of
defensins in intestinal mucosal biopsies, stool and plasma
from individuals with chronic untreated HIV (chronic
progressors), immunologically controlled HIV (elite con-
trollers) and HIV uninfected individuals using ELISA,
immunohistochemistry, quantitative PCR and viral inhi-
bition assays.
Results
Plasma levels of beta defensins were increased in the HIV
controller group compared to HIV progressors, whereas
levels of beta defensins were significantly decreased in
biopsies from chronic progressors. Beta defensin release
was induced by HIV in ex vivo cultured intestinal cells.
Recombinant beta defensins inhibited HIV replication in
vitro.
Conclusion
Beta defensins are upregulated by HIV and inhibit viral
replication in vitro. Chronic progressors, however, had
diminished levels of beta defensins in gut biopsies and in
the plasma. We propose that beta defensins are induced
in HIV infection and have a role in inhibiting viral repli-
cation and preventing intestinal epithelial cell disruption.
In chronic infection, however, their release is diminished,
likely due to epithelial damage in the setting of persistent
viremia and mucosal inflammation.
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